此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

机器人辅助脑干出血微创手术 (RAINBOW-BSH)

2026年9月18日 更新者:Yanbing Yu

机器人辅助脑干出血微创手术策略研究

The purpose of this clinical trial is to observe the improvements in clinical symptoms and imaging outcomes for brainstem hemorrhage using robot-assisted stereotactic puncture, evaluate the clinical efficacy and safety of this treatment, and explore the development of a high-precision, intelligent, and individualized microsurgical diagnosis and treatment process for brainstem hemorrhage. The main questions it aims to address are:

  • Establish a multi-center clinical database for brainstem hemorrhage.
  • Clinically observe and evaluate the intervention effects of robot-assisted stereotactic puncture on brainstem hemorrhage, compare it with the traditional conservative treatment control group, and investigate its efficacy and impact on patient survival, motor evoked potentials, and the degree of neurological deficits.
  • Optimize the Artificial Intelligence (AI) algorithm-based robotic surgical assistance system, and explore the prediction of preoperative brainstem hematoma stability and hematoma path planning.

Participants in the experimental group will:

  • Undergo robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture
  • Receive conservative non-surgical treatment.

If there is a control group: the researchers will compare the conservative non-surgical treatment group to evaluate the effectiveness of robot-assisted stereotactic minimally invasive surgery for brainstem hematoma puncture.

研究概览

研究类型

介入性

注册 (估计的)

142

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Yulian Zhang, M.D.
  • 电话号码:+86-13051581507
  • 邮箱:398824625@qq.com

学习地点

    • Beijing Municipality
      • Beijing、Beijing Municipality、中国、100029
        • 招聘中
        • China-Japan Friendship Hospital
        • 接触:
        • 接触:
        • 副研究员:
          • Xu Yang, M.D.
      • Beijing、Beijing Municipality、中国、100049
        • 招聘中
        • Aerospace Center Hospital
        • 接触:
        • 接触:
    • Guangxi
      • Nanning、Guangxi、中国、530021
        • 招聘中
        • The First Affiliated Hospital of Guangxi Medical University
        • 接触:
    • Hebei
      • Shijiazhuang、Hebei、中国、100190
        • 招聘中
        • Hebei Provincial People's Hospital
        • 接触:
        • 接触:
    • Jiangsu
      • Nanjing、Jiangsu、中国、210008
        • 招聘中
        • Nanjing Drum Tower Hospital
        • 接触:
      • Nantong、Jiangsu、中国、226001
        • 招聘中
        • Affiliated Hospital of Nantong University
        • 接触:
          • JIANHONG SHEN
          • 电话号码:+8613506287516
          • 邮箱:tysjh@163.com
    • Jiangxi
      • Nanchang、Jiangxi、中国、330006
        • 招聘中
        • The Second Affiliated Hospital of Nanchang University
        • 接触:
    • Shanghai Municipality
      • Shanghai、Shanghai Municipality、中国、200040
        • 招聘中
        • Huashan Hospital Fudan University
        • 接触:
      • Shanghai、Shanghai Municipality、中国、201199
        • 招聘中
        • Shanghai Minhang District Central Hospital
        • 接触:
      • Shanghai、Shanghai Municipality、中国、200120
        • 招聘中
        • Shanghai East Hospital, Tongji University
        • 接触:
      • Shanghai、Shanghai Municipality、中国、201508
        • 招聘中
        • Jinshan Hospital, Fudan University
        • 接触:
          • ERSONG WANG
          • 电话号码:wersong@aliyun +8618930815670
    • Tianjin Municipality
      • Tianjin、Tianjin Municipality、中国、300350
        • 招聘中
        • Tianjin Huanhu Hospital
        • 接触:
    • Zhejiang
      • Hangzhou、Zhejiang、中国、310009
        • 招聘中
        • The Second Affiliated Hospital of Zhejiang University School of Medicine
        • 接触:
      • Jinhua、Zhejiang、中国、321000
        • 招聘中
        • Jinhua Municipal Central Hospital / Jinhua Hospital Affiliated to Zhejiang University School of Medicine
        • 接触:
      • Wenzhou、Zhejiang、中国、325000
        • 招聘中
        • The First Affiliated Hospital of Wenzhou Medical University
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Participants must meet all of the following inclusion criteria:

  1. Age ≥18 years at randomization;
  2. Diagnosed with brainstem hemorrhage via imaging (CT, CTA, etc.);
  3. Hematoma volume ≥3 mL;
  4. Glasgow Coma Scale (GCS) score of 3-12;
  5. Available for surgery within 48 hours after onset;
  6. Modified Rankin Scale (mRS) score ≤ 1 prior to this hemorrhage;
  7. Informed consent obtained in accordance with national laws, regulations, and applicable ethics committee requirements.

Patients will be excluded if they meet any of the following criteria:

  1. Hematoma involving other regions such as the supratentorial compartment, basal ganglia, thalamus, midbrain, or ventricles.
  2. Radiologically confirmed cerebral vascular abnormalities including ruptured aneurysms, arteriovenous malformations (AVMs), or Moyamoya disease; hemorrhagic transformation of ischemic infarcts; or recent (within 1 year) recurrence of intracerebral hemorrhage;
  3. Any irreversible coagulation disorder or known coagulopathy; platelet count <100,000/µL; INR >1.4; or use of anticoagulant medication within 7 days before the current hemorrhage;
  4. Current or probable pregnancy;
  5. Patients with concurrent severe illness likely to influence outcome assessment;
  6. Difficulty in follow-up or poor compliance due to any cause.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Robot-assisted minimally invasive puncture and aspiration surgery

The intervention group will receive robot-assisted stereotactic puncture for brainstem hemorrhage

Positioning and surgical operation will be performed according to the robot navigation system protocols. Preoperative imaging data will be used for precise surgical planning, including the construction of a three-dimensional (3D) preoperative visualization model. The 3D reconstruction and CT data will be imported into the AI robot-assisted stereotactic system, which, after mapping to the patient's skull, automatically designs the surgical target, calculates coordinate values, plans the puncture trajectory, and determines the cranial entry point. Different surgical approaches will be selected based on the location and shape of the hematoma, and individualized parameters, including puncture direction and trajectory length, will be generated for each patient. During the procedure, the robot will assist with stereotactic puncture, while the patient's heart rate and blood pressure are closely monitored.

其他名称:
  • 神经外科机器人

According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.

其他名称:
  • 药物治疗
有源比较器:Standard medical management

The control group will undergo conventional medical conservative management.

According to the "Chinese Neurosurgical Expert Consensus on the Diagnosis and Treatment of Primary Brainstem Hemorrhage", conventional medical treatment includes oxygen therapy, specialized nursing care, blood pressure control (maintaining BP at ≤140/90 mmHg), sedation, intracranial pressure reduction, arousal promotion, gastric protection, maintenance of internal homeostasis, infection prevention, neuro-nutrition, brain function support, nutritional support, and overall systemic management; For comatose patients, ensure a patent airway, provide nebulization and sputum clearance, prevent respiratory depression, and improve respiratory function. Closely monitor the patient's condition and provide active symptomatic treatment as needed. Regular cranial CT scans are performed to evaluate intracranial status, and in cases of ventricular hemorrhage or obstructive hydrocephalus, lateral ventricular puncture and drainage may be performed.

其他名称:
  • 药物治疗

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Survival rate
大体时间:60 days

60 days survival rate after follow-up

60 days

次要结果测量

结果测量
措施说明
大体时间
Ordinal shift in mRS scores at 60 days and 6 months
大体时间:60 days and 6 months

The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions.

60 days and 6 months
Favorable functional outcome at 60 days and 6 months (mRS 0-1)
大体时间:60 days and 6 months

The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions.

60 days and 6 months
Functional independence at 60 days and 6 months (mRS 0-2)
大体时间:60 days and 6 months

The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions.

60 days and 6 months
Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire
大体时间:60 days and 6 months

Health-related quality of life (HRQoL) at 60 days and 6 months, assessed by the EQ-5D-5L questionnaire

60 days and 6 months
Utility-weighted mRS at 60 days and 6 months
大体时间:60 days and 6 months

The modified Rankin Scale (mRS) is a standardized tool used to assess the neurological recovery status of stroke patients. The scale is divided into seven levels, ranging from 0 to 6. Higher scores indicate more severe patient conditions.

60 days and 6 months
Cognitive function at 60 days and 6 months
大体时间:60 days and 6 months

Cognitive function at 60 days and 6 months

60 days and 6 months
Total length of hospital stay
大体时间:60 days

Total length of hospital stay

60 days
Costs during hospitalization
大体时间:60 days

Costs during hospitalization

60 days
ICU length of stay
大体时间:60 days

ICU length of stay

60 days
Brainstem hematoma clearance rate on postoperative days 1, 3, and 7
大体时间:1, 3, and 7 days

The change in hematoma volume compared to the preoperative CT scan was assessed 1, 3, and 7 days postoperatively.

1, 3, and 7 days
Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis
大体时间:14 days

Incidence of related complications within 14 days, including pneumonia, aphasia, seizures, and lower-extremity deep vein thrombosis

14 days

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 学习椅:Yanbing Yu, M.D.、China-Japan Friendship Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年5月23日

初级完成 (估计的)

2027年12月1日

研究完成 (估计的)

2028年6月1日

研究注册日期

首次提交

2024年6月6日

首先提交符合 QC 标准的

2024年6月12日

首次发布 (实际的)

2024年6月14日

研究记录更新

最后更新发布 (实际的)

2026年9月23日

上次提交的符合 QC 标准的更新

2026年9月18日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 01084205031

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

The study has not yet begun; we will decide once recruitment starts.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅